These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 33789410)
1. Pneumomediastinum in a Patient with Cannabinoid Hyperemesis Syndrome. Vecchio MJ; Binder WD R I Med J (2013); 2021 Apr; 104(3):49-50. PubMed ID: 33789410 [No Abstract] [Full Text] [Related]
2. [Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome]. Hernández-Ramos I; Parra-Esquivel P; López-Hernández Á; Burillo-Putze G An Sist Sanit Navar; 2019 Aug; 42(2):227-230. PubMed ID: 31133765 [TBL] [Abstract][Full Text] [Related]
3. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids. Hopkins CY; Gilchrist BL J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687 [TBL] [Abstract][Full Text] [Related]
4. More than bargained for: pneumomediastinum and subcutaneous emphysema associated with synthetic cannabinoid use. Young R; Molina A BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30580314 [No Abstract] [Full Text] [Related]
5. Cannabinoid Hyperemesis Syndrome Presenting With Spontaneous Pneumomediastinum. Davis W; Frye K; Shah D; Cagande C Prim Care Companion CNS Disord; 2020 Mar; 22(2):. PubMed ID: 32237289 [No Abstract] [Full Text] [Related]
6. What Is Cannabinoid Hyperemesis Syndrome? Pizarro-Osilla C J Emerg Nurs; 2018 Nov; 44(6):665-667. PubMed ID: 30415738 [No Abstract] [Full Text] [Related]
19. Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure. Argamany JR; Reveles KR; Duhon B Am J Emerg Med; 2016 Apr; 34(4):765.e1-2. PubMed ID: 26422191 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice. Kast KA; Gershengoren L J Psychiatr Pract; 2018 Jan; 24(1):51-55. PubMed ID: 29320384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]